Q2 2025 Earnings Call Transcript July 30, 2025 Altria Group, Inc. beats earnings expectations. Reported EPS is $1.44, ...

Acquisition strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE® (zuranolone), and a novel CNS discovery platform, accelerating mid- t ...

Fed policymakers don't make rate decisions ahead of time, so Powell's response is typical. But a quirk in the Fed's calendar ...